Innodem Neurosciences
Innodem Neurosciences is a leading digital biomarker and AI company specializing in eye tracking technology for neurological assessments. Their flagship product, ETNA™, is designed to monitor the progression of neurodegenerative diseases such as multiple sclerosis, Alzheimer's, and Parkinson's. The company differentiates itself through its patented technology and ongoing clinical trials, which provide valuable data for machine learning algorithms to enhance predictability models. With a strong focus on patient-centric solutions, Innodem is positioned to redefine standards in healthcare and improve patient outcomes.
Innodem Neurosciences
Innodem Neurosciences is a leading digital biomarker and AI company specializing in eye tracking technology for neurological assessments. Their flagship product, ETNA™, is designed to monitor the progression of neurodegenerative diseases such as multiple sclerosis, Alzheimer's, and Parkinson's. The company differentiates itself through its patented technology and ongoing clinical trials, which provide valuable data for machine learning algorithms to enhance predictability models. With a strong focus on patient-centric solutions, Innodem is positioned to redefine standards in healthcare and improve patient outcomes.